B2B Central

Pharmaceutical manufacturing

09 Mar 2020

Bringing access to chronic medication to the furthest reaches of SA

By Staff Writer

The Cipla Foundation has recently landed its 20th pick-up point facility in South Africa. Through its Sha’p Left initiative the Cipla Foundation is providing high-quality, customised chronic medicine PUPs around the country. Improving access to chronic medication The Central Chronic Medication Dispensing and Distribution (CCMDD) programme is a National Department of Health initiative working to...
09 Mar 2020

More global research needed to combat Coronavirus outbreak

By Staff Writer

More research and collaboration are needed worldwide to combat the COVID-19 outbreak. This is the view of leading data and analytics company, GlobalData. In light of the outbreak GlobalData has analysed several of the largest COVID-19 clinical trials in terms of participant size. Preventative effects of Chinese medicine Mohamed Abukar, Clinical Trials analyst at GlobalData,...
09 Mar 2020

Wacker launches Libatec for developing Live Microbial Products

By Staff Writer

Wacker Biotech is marketing its technology platform for developing and manufacturing Live Microbial Products (LMPs) under the brand name Libatec. LMPs are a promising class of therapeutic products that open the door to new medical treatments. The Wacker Group is bundling its biopharmaceutical activities within Wacker Biotech, a CDMO (contract development and manufacturing organisation) notable...
10 Feb 2020

First AI-generated drug enters clinical trials

By Staff Writer

In 2020, big data and artificial intelligence (AI) will continue to trend as integral parts of the future of pharmaceutical research and healthcare service delivery, GlobalData predicts. The company’s latest annual outlook report, The State of the Biopharmaceutical Industry – 2020, reveals that 65 percent of pharma managers and executives surveyed selected big data (32...
03 Feb 2020

How astronauts will make their own medication in space

By Staff Writer

By: Allie Nawrat GlobalData’s pharmaceutical technology writer Given the shelf life of most commercially available medicines is two years or less, astronauts have to be able to manufacture medication on-demand and on-board their spacecraft. NASA’s Translational Research Institute for Space Health (TRISH) has funded innovative projects seeking to better protect astronauts’ health during deep space...
17 Jan 2020

Sustainably sourced white mulberry tree extract gets to the root of anti-aging

By Staff Writer

Clariant Active Ingredients has launched Prenylium – the first product unveiled in its new partnership with French biotechnology company, Plant Advanced Technologies (PAT). Rich in rare prenylated flavonoids content, Prenylium is a unique Morus alba tree root extract, highly efficient at protecting the skin matrisome from degradation that occurs with time and UV exposure. It...
17 Jan 2020

Growth for large MCap pharma companies in Q3 2019

By Staff Writer

In Q3 of 2019, 14 pharmaceutical companies listed in the top 20 players by Market Capitalisation (MCap) registered positive performances; however, the top five companies witnessed a five percent decline as compared to Q2, according to data and analytics firm GlobalData. Madeleine Roche, business fundamentals associate analyst, comments: ‘Johnson & Johnson continues to maintain the...
09 Jan 2020

Werum IT Solutions launches a smart biometric authentication solution

By Staff Writer

Werum IT Solutions has launched K.ME-IN, a biometric authentication solution with Nymi for Werum’s PAS-X Manufacturing Execution System (MES). The new solution will allow users on the pharmaceutical or biopharmaceutical shop floor to securely and seamlessly authenticate to systems, devices and machines via a smart wristband. In the future, K.ME-IN will be extended to allow...
11 Dec 2019

Natural and sustainable starch amazes the personal care market

By Staff Writer

Amaze Nordic Barley, derived from barley starch, addresses the fast-growing consumer demand for natural, biodegradable and clean label ingredients. The certified natural starch can replace petrochemical-based products in a variety of personal care applications. Minimal environmental impact The product is the result of a partnership between Nouryon and Oat Services, a UK company specialising in...
02 Dec 2019

Symrise presents nature identical CBD

By Staff Writer

Symrise presented a top-class new development at the CPhI in Frankfurt am Main: Canapure. The cannabidiol (CBD) is identical to nature and complies with the guidelines of Good Manufacturing Practice (GMP), which govern rules of good pharmaceutical manufacturing practice including hygiene requirements and monitoring. Canapure serves as both a valuable active pharmaceutical ingredient and an...
02 Dec 2019

How to identify non-compliances in molded glass bottles for pharmaceuticals

By Staff Writer

SGD Pharma will launch the first application to identify non-compliances in molded glass bottles intended for the pharmaceutical industry at CPhl WW 2019. Resulting from a development project between SGD Pharma Quality and Marketing departments, this new digital tool makes it possible to identify non-compliances that may be discovered during an incoming inspection or during...
04 Nov 2019

Symrise deodorant active proven to be microbiome friendly

By Staff Writer

Symrise has launched an in depth investigation into its deodorant active SymDeo B125. Long term efficacy of the active has been known for many years, however Research & Development has discovered additional key advantages: In contrast to the conventional antimicrobial triclosan, SymDeo B125 has no negative impact on the axillary microbiome. Microbiome friendly 10 years...

Visit the official COVID-19 government website to stay informed: sacoronavirus.co.za